Literature DB >> 11853719

Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema.

Erika Shimizu1, Hideharu Funatsu, Hidetoshi Yamashita, Tetsuji Yamashita, Sadao Hori.   

Abstract

PURPOSE: To find a predictor in the pathogenesis of macular edema, we investigated ocular and systemic risk factors.
METHODS: One hundred and fifty-nine patients with mild diabetic retinopathy who showed one or more soft exudates were recruited. We selected the possible predictors on the basis of relevant factors, including concentration of vascular endothelial growth factor, interleukin-6 (IL-6), transforming growth factor (TGF)-beta(1), tumor necrosis factor (TNF)-alpha, and lipoprotein(a) in plasma, and serum level of von Willebrand factor and thrombomodulin.
RESULTS: Macular edema was not detected in 94 eyes; focal macular edema was detected in 46 eyes; diffuse macular edema was detected in 18 eyes; and cystoid macular edema was present in 1 eye. The plasma level of IL-6 concentration and the state of the posterior vitreous detachment (PVD) correlated significantly with the severity of macular edema (odds ratios = 3.68, 1.70, respectively). Other risk factors were not significantly associated with macular edema. We estimated the probability of macular edema according to the IL-6 level in plasma and the state of the PVD, and were able to predict the probability of macular edema.
CONCLUSION: The results of the present study indicate that IL-6 concentration in plasma and the state of the PVD can be predictors of macular edema.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853719     DOI: 10.1016/s0021-5155(01)00452-x

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  11 in total

1.  Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Authors:  Sachi Abe; Teiko Yamamoto; Yoshiko Kashiwagi; Eriko Kirii; Sakiko Goto; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2013-10-11       Impact factor: 2.447

2.  Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.

Authors:  H Funatsu; H Yamashita; H Noma; T Mimura; K Sakata; S Hori
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy.

Authors:  Rebekah Robinson; Mukund Srinivasan; Arul Shanmugam; Alexander Ward; Veena Ganapathy; Justin Bloom; Ashok Sharma; Shruti Sharma
Journal:  Redox Biol       Date:  2020-05-13       Impact factor: 11.799

4.  Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells.

Authors:  Maria L Valle; Janine Dworshak; Ashok Sharma; Ahmed S Ibrahim; Mohamed Al-Shabrawey; Shruti Sharma
Journal:  Exp Eye Res       Date:  2018-09-18       Impact factor: 3.467

5.  Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy.

Authors:  Shruti Sharma
Journal:  Front Physiol       Date:  2021-05-19       Impact factor: 4.566

6.  Alterations in monocyte CD16 in association with diabetes complications.

Authors:  Danqing Min; Belinda Brooks; Jencia Wong; Robert Salomon; Wensheng Bao; Brian Harrisberg; Stephen M Twigg; Dennis K Yue; Susan V McLennan
Journal:  Mediators Inflamm       Date:  2012-12-18       Impact factor: 4.711

7.  Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children.

Authors:  Katarzyna Zorena; Jolanta Myśliwska; Małgorzata Myśliwiec; Anna Balcerska; Łukasz Hak; Paweł Lipowski; Krystyna Raczyńska
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

8.  Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice.

Authors:  Anna V Zetterqvist; Fabiana Blanco; Jenny Öhman; Olga Kotova; Lisa M Berglund; Sergio de Frutos Garcia; Raed Al-Naemi; Maria Wigren; Paul G McGuire; Laura V Gonzalez Bosc; Maria F Gomez
Journal:  J Diabetes Res       Date:  2015-03-31       Impact factor: 4.011

Review 9.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

Review 10.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.